SlideShare a Scribd company logo
Evaluation of the Antibiotic Guardian
(AG) campaign
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
The National Institute for Health
Research Health Protection Research
Unit in Evaluation of Interventions at
University of Bristol
Katerina Chaintarli, DVM, MSc
Background-Aims
• Aim of European Antibiotic Awareness Day (EAAD): Raise awareness
towards antibiotic use
• England has participated in EAAD activities since 2008
• UK EAAD 2014:
• Move from raising awareness to increasing engagement and changing behaviour
• Public Health England developed the Antibiotic Guardian campaign available all
year round
online pledge system
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Pledge system (http://antibioticguardian.com)
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Background-Aims
• Purpose of Antibiotic Guardian (AG) campaign:
• Increase engagement with the rising threat of Antimicrobial Resistance (AMR)
• Concrete personal and collective action to help keep antibiotics active
• Provide a system to measure behaviour change
• First example of online pledge system to improve AMR related knowledge
and behaviour amongst healthcare professionals and the general public
• Aim of current evaluation: assess whether the AG achieved its goals
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Methods - Questionnaire
• Online questionnaire: Evaluation of the Antibiotic Guardian campaign
2014
• Sent via e-mail to 9016 out of all 11833 Antibiotic Guardians who consented
for follow up (3rd of February 2015)
• Survey included questions on:
• Type of pledge & Motivation
• Change in behaviour (acting according to pledge)
• Knowledge acquired
• Clarity of promotion materials
• Demographics (age, sex, health-related profession, use of social media)
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Methods – Statistical Analysis
• Distribution of demographic variables
• Questions analysed as the outcomes of interest:
• Change in behaviour: “Since you became an Antibiotic Guardian, have you acted
in line with your pledge?” (categorical)
• Change in knowledge: “After becoming an Antibiotic Guardian, do you feel that
you have acquired more knowledge on what antibiotic resistance is?” (binary)
• Promotion of the AG campaign: “Indicate your agreement with the statement: “I
think the AG campaign is well promoted” (categorical)
• Logistic and Ordinal Logistic regression models, adjusted for age, sex
and pledge group used to estimate associations
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Results - Respondents
• 2478 AGs responded: 27.5% response rate
• 1696 pledged as healthcare professionals (68%)
• 782 pledged as members of public (32%)
↓
similar to proportions at total population of 11,833 AGs
• 76.9% were connected to the healthcare system
• 96.3% had prior knowledge of AMR
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Results - Demographics
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
• 73.5% female
• 27.5% 45-54
years old
Results - Behaviour
• 43.9% remembered completely the meaning of their pledge
• 63.4% reported always acting according to their pledge
• Members of public more likely to act according to their pledge than
healthcare professionals (OR=3.60, CI: 2.88-4.51)
• Respondents without positive pre-campaign pledge behaviour less likely to
have positive post campaign pledge behaviour (OR=0.23, CI: 0.16-0.34)
• AGs that remembered the pledge more likely to have positive post
campaign behaviour (OR=1.96, CI: 1.63-2.36)
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Results - Knowledge
• 44.5% acquired more knowledge about AMR post campaign
• Sense of personal responsibility towards tackling AMR increased by
12.2% post campaign
• People confused about AMR prior to the AG campaign acquired more
knowledge after the campaign (OR =3.10, CI: 1.36 – 7.09)
• Respondents without pre-campaign knowledge more likely to acquire
knowledge on AMR post campaign (OR=4.21, CI: 2.04 – 8.67)
• Members of the public less likely to have acquired more knowledge post
campaign than healthcare professionals (OR= 0.79, CI: 0.66 – 0.96)
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Results - Promotion
• 61.7% agreed to different extents that the AG campaign was well
promoted
• 56.7% seemed to think that the website itself was the best source of
information
but
more than half of AGs have not seen most promotion materials
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Conclusion
• Good response of an overall representative sample in terms of proportions
of different pledge groups
• Effective in achieving positive changes in behaviour and an increase in
knowledge amongst people with prior awareness of the topic
• Less successful in engaging people without previous professional or
personal experience of AMR
• Majority thought the campaign was well promoted but most materials were
not seen
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Recommendations
• Regular communication with pledgees via e-mails or newsletters to
remind their pledge and provide information
• Engage wider members of public → initiatives for alternative promotion
methods to get the public aware and engaged with the campaign
• Evaluations should be built into the design of future campaigns → capture
pre and post campaign effects
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Next steps
• Qualitative methods applied to explore the results from the quantitative
analysis
Qualitative interview study will seek to identify how the AG campaign was engaged
with and the mechanisms of impact from the perspective of those who became AG
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
Thank you
Acknowledgements
•Public Health England, AMRs and HCAI Programme Team, London: Dr Diane Ashiru-Oredope, Alex
Bhattacharya
•Public Health England, Field Epidemiology Services, Bristol: Dr Maya Gobin, Dr Isabel Oliver
•Health Protection Research Unit in Evaluation of Interventions, School of Social and Community
Medicine, University of Bristol: Dr Suzanne M. Ingle
The study was supported by the NIHR Health Protection Research Unit in Evaluation of Interventions. The views expressed are
those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.
Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope

More Related Content

What's hot

EMPHNET-PHE COurse: Module08 ethical codes and frameworks
EMPHNET-PHE COurse: Module08 ethical codes and frameworksEMPHNET-PHE COurse: Module08 ethical codes and frameworks
EMPHNET-PHE COurse: Module08 ethical codes and frameworks
Dr Ghaiath Hussein
 
Why should healthcare professionals care about social media?
Why should healthcare professionals care about social media?Why should healthcare professionals care about social media?
Why should healthcare professionals care about social media?
Innovation Agency
 
Steven wilson research outline presentation
Steven wilson research outline presentationSteven wilson research outline presentation
Steven wilson research outline presentation
smwilson1
 
Social Media Marketing Life Science Alley March 2013
Social Media Marketing   Life Science Alley March 2013Social Media Marketing   Life Science Alley March 2013
Social Media Marketing Life Science Alley March 2013
Elise Schadauer
 
Mobile Health Trends
Mobile Health TrendsMobile Health Trends
Mobile Health Trends
Kent State University
 
Summit @ HIMSS- IoT and Personal Connected Health
Summit @ HIMSS-  IoT and Personal Connected HealthSummit @ HIMSS-  IoT and Personal Connected Health
Summit @ HIMSS- IoT and Personal Connected Health
Kent State University
 
Pre record lan april webinar1-final (2)
Pre record lan april webinar1-final (2)Pre record lan april webinar1-final (2)
Pre record lan april webinar1-final (2)
dmphillips1
 
M. Chris Gibbons - Health IT and Healthcare Disparities
M. Chris Gibbons - Health IT and Healthcare DisparitiesM. Chris Gibbons - Health IT and Healthcare Disparities
M. Chris Gibbons - Health IT and Healthcare Disparities
Plain Talk 2015
 
Integrating Wellness Into Cancer Care
Integrating Wellness Into Cancer CareIntegrating Wellness Into Cancer Care
Integrating Wellness Into Cancer Care
Current Oncology
 
Building A Chronic Care Management Program That Can Scale
Building A Chronic Care Management Program That Can ScaleBuilding A Chronic Care Management Program That Can Scale
Building A Chronic Care Management Program That Can Scale
VSee
 
Dr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
Dr. Michael D. Apley - Antibiotic Resistance: A One Health PerspectiveDr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
Dr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
John Blue
 
Mobile technology impact AGA Tech Summit - March 2015
Mobile technology impact   AGA Tech Summit - March 2015Mobile technology impact   AGA Tech Summit - March 2015
Mobile technology impact AGA Tech Summit - March 2015
Kent State University
 
HepTREC Marketing Plan
HepTREC Marketing PlanHepTREC Marketing Plan
HepTREC Marketing Plan
cstam
 
Womens' Experience of Stop Smoking Support during Pregnancy
Womens' Experience of Stop Smoking Support during PregnancyWomens' Experience of Stop Smoking Support during Pregnancy
Womens' Experience of Stop Smoking Support during Pregnancy
ashnw
 
Research Abstracts Vtrim's online healthy weight management program
Research Abstracts Vtrim's online healthy weight management programResearch Abstracts Vtrim's online healthy weight management program
Research Abstracts Vtrim's online healthy weight management program
kmyerson
 
Marquez Collaborative Improvement
Marquez Collaborative ImprovementMarquez Collaborative Improvement
Marquez Collaborative Improvement
CORE Group
 
Evaluating a mobile app for healthier snacking behaviours
Evaluating a mobile app for healthier snacking behavioursEvaluating a mobile app for healthier snacking behaviours
Evaluating a mobile app for healthier snacking behaviours
Yitong HUANG
 
Digital Health - Hypertension Case Study
Digital Health - Hypertension Case StudyDigital Health - Hypertension Case Study
Digital Health - Hypertension Case Study
Satnam Bains
 
EuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum
 
Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani
Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa QuintilianiCreate to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani
Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani
CFTCC
 

What's hot (20)

EMPHNET-PHE COurse: Module08 ethical codes and frameworks
EMPHNET-PHE COurse: Module08 ethical codes and frameworksEMPHNET-PHE COurse: Module08 ethical codes and frameworks
EMPHNET-PHE COurse: Module08 ethical codes and frameworks
 
Why should healthcare professionals care about social media?
Why should healthcare professionals care about social media?Why should healthcare professionals care about social media?
Why should healthcare professionals care about social media?
 
Steven wilson research outline presentation
Steven wilson research outline presentationSteven wilson research outline presentation
Steven wilson research outline presentation
 
Social Media Marketing Life Science Alley March 2013
Social Media Marketing   Life Science Alley March 2013Social Media Marketing   Life Science Alley March 2013
Social Media Marketing Life Science Alley March 2013
 
Mobile Health Trends
Mobile Health TrendsMobile Health Trends
Mobile Health Trends
 
Summit @ HIMSS- IoT and Personal Connected Health
Summit @ HIMSS-  IoT and Personal Connected HealthSummit @ HIMSS-  IoT and Personal Connected Health
Summit @ HIMSS- IoT and Personal Connected Health
 
Pre record lan april webinar1-final (2)
Pre record lan april webinar1-final (2)Pre record lan april webinar1-final (2)
Pre record lan april webinar1-final (2)
 
M. Chris Gibbons - Health IT and Healthcare Disparities
M. Chris Gibbons - Health IT and Healthcare DisparitiesM. Chris Gibbons - Health IT and Healthcare Disparities
M. Chris Gibbons - Health IT and Healthcare Disparities
 
Integrating Wellness Into Cancer Care
Integrating Wellness Into Cancer CareIntegrating Wellness Into Cancer Care
Integrating Wellness Into Cancer Care
 
Building A Chronic Care Management Program That Can Scale
Building A Chronic Care Management Program That Can ScaleBuilding A Chronic Care Management Program That Can Scale
Building A Chronic Care Management Program That Can Scale
 
Dr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
Dr. Michael D. Apley - Antibiotic Resistance: A One Health PerspectiveDr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
Dr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
 
Mobile technology impact AGA Tech Summit - March 2015
Mobile technology impact   AGA Tech Summit - March 2015Mobile technology impact   AGA Tech Summit - March 2015
Mobile technology impact AGA Tech Summit - March 2015
 
HepTREC Marketing Plan
HepTREC Marketing PlanHepTREC Marketing Plan
HepTREC Marketing Plan
 
Womens' Experience of Stop Smoking Support during Pregnancy
Womens' Experience of Stop Smoking Support during PregnancyWomens' Experience of Stop Smoking Support during Pregnancy
Womens' Experience of Stop Smoking Support during Pregnancy
 
Research Abstracts Vtrim's online healthy weight management program
Research Abstracts Vtrim's online healthy weight management programResearch Abstracts Vtrim's online healthy weight management program
Research Abstracts Vtrim's online healthy weight management program
 
Marquez Collaborative Improvement
Marquez Collaborative ImprovementMarquez Collaborative Improvement
Marquez Collaborative Improvement
 
Evaluating a mobile app for healthier snacking behaviours
Evaluating a mobile app for healthier snacking behavioursEvaluating a mobile app for healthier snacking behaviours
Evaluating a mobile app for healthier snacking behaviours
 
Digital Health - Hypertension Case Study
Digital Health - Hypertension Case StudyDigital Health - Hypertension Case Study
Digital Health - Hypertension Case Study
 
EuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum 2013 - Day 1 | Etienne Richer
EuroBioForum 2013 - Day 1 | Etienne Richer
 
Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani
Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa QuintilianiCreate to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani
Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani
 

Viewers also liked

MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...
MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...
MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...
European Centre for Disease Prevention and Control
 
Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...
Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...
Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...
European Centre for Disease Prevention and Control
 
Global Action Plan on Antimicrobial Resistance, Marc Sprenger
Global Action Plan on Antimicrobial Resistance, Marc SprengerGlobal Action Plan on Antimicrobial Resistance, Marc Sprenger
Global Action Plan on Antimicrobial Resistance, Marc Sprenger
European Centre for Disease Prevention and Control
 
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
European Centre for Disease Prevention and Control
 
Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...
Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...
Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...
European Centre for Disease Prevention and Control
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
European Centre for Disease Prevention and Control
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
European Centre for Disease Prevention and Control
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
European Centre for Disease Prevention and Control
 
Antibiotic resistance: a tragedy of the commons, Prof. Jan Kluytmans
Antibiotic resistance: a tragedy of the commons, Prof. Jan KluytmansAntibiotic resistance: a tragedy of the commons, Prof. Jan Kluytmans
Antibiotic resistance: a tragedy of the commons, Prof. Jan Kluytmans
European Centre for Disease Prevention and Control
 
Antibacterial paper
Antibacterial paperAntibacterial paper
Antibacterial paper
Anjum Hashmi MPH
 
Building the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using RBuilding the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using R
European Centre for Disease Prevention and Control
 
Guidance on programmatic management of latent TB infection: applicability for...
Guidance on programmatic management of latent TB infection: applicability for...Guidance on programmatic management of latent TB infection: applicability for...
Guidance on programmatic management of latent TB infection: applicability for...
European Centre for Disease Prevention and Control
 
Antimicrobal Resistance
Antimicrobal ResistanceAntimicrobal Resistance
Antimicrobal Resistance
Dr. Vachagan Harutyunyan
 
Antimicrobial Resistance
Antimicrobial ResistanceAntimicrobial Resistance
Antimicrobial Resistance
WirralCT
 
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
European Centre for Disease Prevention and Control
 
Scaling up HIV testing: the role of self-testing
Scaling up HIV testing: the role of self-testingScaling up HIV testing: the role of self-testing
Scaling up HIV testing: the role of self-testing
European Centre for Disease Prevention and Control
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
European Centre for Disease Prevention and Control
 
HIV among migrants, what do we know?
HIV among migrants, what do we know?HIV among migrants, what do we know?
HIV among migrants, what do we know?
European Centre for Disease Prevention and Control
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 

Viewers also liked (20)

MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...
MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...
MERS-CoV: Extent of infection in and transmission to humans, Dr. Maria Van Ke...
 
Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...
Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...
Latest EU-wide data: Resistance to last-line antibiotics continues to cause c...
 
Global Action Plan on Antimicrobial Resistance, Marc Sprenger
Global Action Plan on Antimicrobial Resistance, Marc SprengerGlobal Action Plan on Antimicrobial Resistance, Marc Sprenger
Global Action Plan on Antimicrobial Resistance, Marc Sprenger
 
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
Silvia Declich: Experiences and challenges in monitoring migrant health in mi...
 
Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...
Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...
Marco Cavaleri: Post-approval benefit risk monitoring of vaccines: EMA perspe...
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
 
Antibiotic resistance: a tragedy of the commons, Prof. Jan Kluytmans
Antibiotic resistance: a tragedy of the commons, Prof. Jan KluytmansAntibiotic resistance: a tragedy of the commons, Prof. Jan Kluytmans
Antibiotic resistance: a tragedy of the commons, Prof. Jan Kluytmans
 
Antibacterial paper
Antibacterial paperAntibacterial paper
Antibacterial paper
 
Building the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using RBuilding the next generation of statistical tools for outbreak response using R
Building the next generation of statistical tools for outbreak response using R
 
Guidance on programmatic management of latent TB infection: applicability for...
Guidance on programmatic management of latent TB infection: applicability for...Guidance on programmatic management of latent TB infection: applicability for...
Guidance on programmatic management of latent TB infection: applicability for...
 
Antimicrobal Resistance
Antimicrobal ResistanceAntimicrobal Resistance
Antimicrobal Resistance
 
Antimicrobial Resistance
Antimicrobial ResistanceAntimicrobial Resistance
Antimicrobial Resistance
 
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
 
Scaling up HIV testing: the role of self-testing
Scaling up HIV testing: the role of self-testingScaling up HIV testing: the role of self-testing
Scaling up HIV testing: the role of self-testing
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
 
HIV among migrants, what do we know?
HIV among migrants, what do we know?HIV among migrants, what do we know?
HIV among migrants, what do we know?
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
 

Similar to Evaluation of the Antibiotic Guardian campaign to help tackle antimicrobial resistance, Katerina Chaintarl

EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
Dr Ghaiath Hussein
 
Learning Health Care Systems
Learning Health Care SystemsLearning Health Care Systems
Learning Health Care Systems
Group Health Cooperative
 
Applying for funding and involving consumers
Applying for funding and involving consumersApplying for funding and involving consumers
Applying for funding and involving consumers
Cancer Council NSW
 
Health Impact Assessment - 2014
Health Impact Assessment - 2014Health Impact Assessment - 2014
Health Impact Assessment - 2014
Ben Harris-Roxas
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
NHSNWRD
 
Shared Decision Making in England
Shared Decision Making in EnglandShared Decision Making in England
Shared Decision Making in England
Informed Medical Decisions Foundation
 
Let's talk people in research sept 2014
Let's talk people in research   sept 2014Let's talk people in research   sept 2014
Let's talk people in research sept 2014
Simon Denegri
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
Fight Colorectal Cancer
 
Making it stick: when asking, telling and begging just isn’t enough
Making it stick: when asking, telling and begging just isn’t enoughMaking it stick: when asking, telling and begging just isn’t enough
Making it stick: when asking, telling and begging just isn’t enough
Canadian Patient Safety Institute
 
What’s Working In Small Business Wellness with Ken Holtyn
What’s Working In Small Business Wellness with Ken HoltynWhat’s Working In Small Business Wellness with Ken Holtyn
What’s Working In Small Business Wellness with Ken Holtyn
HPCareer.Net / State of Wellness Inc.
 
suzette woodward breakout collaborative launch
suzette woodward breakout collaborative launchsuzette woodward breakout collaborative launch
suzette woodward breakout collaborative launch
NHS Improving Quality
 
Antibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham WorkshopAntibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham Workshop
4 All of Us
 
Quantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their PatientsQuantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their Patients
Social Media Today
 
Implementation science
Implementation scienceImplementation science
Implementation science
Rukman Mecca
 
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
MargaretFarrell
 
Driving progress in healthcare through NHS research
Driving progress in healthcare through NHS researchDriving progress in healthcare through NHS research
Driving progress in healthcare through NHS research
Health and Care Innovation Expo
 
Linking Clinical Care and Communities for Improved Prevention
Linking Clinical Care and Communities for Improved PreventionLinking Clinical Care and Communities for Improved Prevention
Linking Clinical Care and Communities for Improved Prevention
AHRQ Health Care Innovations Exchange
 
Patient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experiencePatient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experience
GuíaSalud
 
Beneficence in Nursing practice and Human research
Beneficence in Nursing practice and Human researchBeneficence in Nursing practice and Human research
Beneficence in Nursing practice and Human research
AgezegnAsegidMrekonn
 
Cigbreak - a novel smartphone game for smoking cessation
Cigbreak - a novel smartphone game for smoking cessationCigbreak - a novel smartphone game for smoking cessation
Cigbreak - a novel smartphone game for smoking cessation
Games for Health Europe
 

Similar to Evaluation of the Antibiotic Guardian campaign to help tackle antimicrobial resistance, Katerina Chaintarl (20)

EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
 
Learning Health Care Systems
Learning Health Care SystemsLearning Health Care Systems
Learning Health Care Systems
 
Applying for funding and involving consumers
Applying for funding and involving consumersApplying for funding and involving consumers
Applying for funding and involving consumers
 
Health Impact Assessment - 2014
Health Impact Assessment - 2014Health Impact Assessment - 2014
Health Impact Assessment - 2014
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)
 
Shared Decision Making in England
Shared Decision Making in EnglandShared Decision Making in England
Shared Decision Making in England
 
Let's talk people in research sept 2014
Let's talk people in research   sept 2014Let's talk people in research   sept 2014
Let's talk people in research sept 2014
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
 
Making it stick: when asking, telling and begging just isn’t enough
Making it stick: when asking, telling and begging just isn’t enoughMaking it stick: when asking, telling and begging just isn’t enough
Making it stick: when asking, telling and begging just isn’t enough
 
What’s Working In Small Business Wellness with Ken Holtyn
What’s Working In Small Business Wellness with Ken HoltynWhat’s Working In Small Business Wellness with Ken Holtyn
What’s Working In Small Business Wellness with Ken Holtyn
 
suzette woodward breakout collaborative launch
suzette woodward breakout collaborative launchsuzette woodward breakout collaborative launch
suzette woodward breakout collaborative launch
 
Antibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham WorkshopAntibiotic Guardian Birmingham Workshop
Antibiotic Guardian Birmingham Workshop
 
Quantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their PatientsQuantified Self: Helping Physicians Empower Their Patients
Quantified Self: Helping Physicians Empower Their Patients
 
Implementation science
Implementation scienceImplementation science
Implementation science
 
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
 
Driving progress in healthcare through NHS research
Driving progress in healthcare through NHS researchDriving progress in healthcare through NHS research
Driving progress in healthcare through NHS research
 
Linking Clinical Care and Communities for Improved Prevention
Linking Clinical Care and Communities for Improved PreventionLinking Clinical Care and Communities for Improved Prevention
Linking Clinical Care and Communities for Improved Prevention
 
Patient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experiencePatient, carer & public involvement in clinical guidelines: the NICE experience
Patient, carer & public involvement in clinical guidelines: the NICE experience
 
Beneficence in Nursing practice and Human research
Beneficence in Nursing practice and Human researchBeneficence in Nursing practice and Human research
Beneficence in Nursing practice and Human research
 
Cigbreak - a novel smartphone game for smoking cessation
Cigbreak - a novel smartphone game for smoking cessationCigbreak - a novel smartphone game for smoking cessation
Cigbreak - a novel smartphone game for smoking cessation
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 

Recently uploaded

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 

Recently uploaded (20)

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 

Evaluation of the Antibiotic Guardian campaign to help tackle antimicrobial resistance, Katerina Chaintarl

  • 1. Evaluation of the Antibiotic Guardian (AG) campaign Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope The National Institute for Health Research Health Protection Research Unit in Evaluation of Interventions at University of Bristol Katerina Chaintarli, DVM, MSc
  • 2. Background-Aims • Aim of European Antibiotic Awareness Day (EAAD): Raise awareness towards antibiotic use • England has participated in EAAD activities since 2008 • UK EAAD 2014: • Move from raising awareness to increasing engagement and changing behaviour • Public Health England developed the Antibiotic Guardian campaign available all year round online pledge system Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 3. Pledge system (http://antibioticguardian.com) Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 4. Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 5. Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 6. Background-Aims • Purpose of Antibiotic Guardian (AG) campaign: • Increase engagement with the rising threat of Antimicrobial Resistance (AMR) • Concrete personal and collective action to help keep antibiotics active • Provide a system to measure behaviour change • First example of online pledge system to improve AMR related knowledge and behaviour amongst healthcare professionals and the general public • Aim of current evaluation: assess whether the AG achieved its goals Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 7. Methods - Questionnaire • Online questionnaire: Evaluation of the Antibiotic Guardian campaign 2014 • Sent via e-mail to 9016 out of all 11833 Antibiotic Guardians who consented for follow up (3rd of February 2015) • Survey included questions on: • Type of pledge & Motivation • Change in behaviour (acting according to pledge) • Knowledge acquired • Clarity of promotion materials • Demographics (age, sex, health-related profession, use of social media) Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 8. Methods – Statistical Analysis • Distribution of demographic variables • Questions analysed as the outcomes of interest: • Change in behaviour: “Since you became an Antibiotic Guardian, have you acted in line with your pledge?” (categorical) • Change in knowledge: “After becoming an Antibiotic Guardian, do you feel that you have acquired more knowledge on what antibiotic resistance is?” (binary) • Promotion of the AG campaign: “Indicate your agreement with the statement: “I think the AG campaign is well promoted” (categorical) • Logistic and Ordinal Logistic regression models, adjusted for age, sex and pledge group used to estimate associations Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 9. Results - Respondents • 2478 AGs responded: 27.5% response rate • 1696 pledged as healthcare professionals (68%) • 782 pledged as members of public (32%) ↓ similar to proportions at total population of 11,833 AGs • 76.9% were connected to the healthcare system • 96.3% had prior knowledge of AMR Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 10. Results - Demographics Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope • 73.5% female • 27.5% 45-54 years old
  • 11. Results - Behaviour • 43.9% remembered completely the meaning of their pledge • 63.4% reported always acting according to their pledge • Members of public more likely to act according to their pledge than healthcare professionals (OR=3.60, CI: 2.88-4.51) • Respondents without positive pre-campaign pledge behaviour less likely to have positive post campaign pledge behaviour (OR=0.23, CI: 0.16-0.34) • AGs that remembered the pledge more likely to have positive post campaign behaviour (OR=1.96, CI: 1.63-2.36) Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 12. Results - Knowledge • 44.5% acquired more knowledge about AMR post campaign • Sense of personal responsibility towards tackling AMR increased by 12.2% post campaign • People confused about AMR prior to the AG campaign acquired more knowledge after the campaign (OR =3.10, CI: 1.36 – 7.09) • Respondents without pre-campaign knowledge more likely to acquire knowledge on AMR post campaign (OR=4.21, CI: 2.04 – 8.67) • Members of the public less likely to have acquired more knowledge post campaign than healthcare professionals (OR= 0.79, CI: 0.66 – 0.96) Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 13. Results - Promotion • 61.7% agreed to different extents that the AG campaign was well promoted • 56.7% seemed to think that the website itself was the best source of information but more than half of AGs have not seen most promotion materials Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 14. Conclusion • Good response of an overall representative sample in terms of proportions of different pledge groups • Effective in achieving positive changes in behaviour and an increase in knowledge amongst people with prior awareness of the topic • Less successful in engaging people without previous professional or personal experience of AMR • Majority thought the campaign was well promoted but most materials were not seen Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 15. Recommendations • Regular communication with pledgees via e-mails or newsletters to remind their pledge and provide information • Engage wider members of public → initiatives for alternative promotion methods to get the public aware and engaged with the campaign • Evaluations should be built into the design of future campaigns → capture pre and post campaign effects Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 16. Next steps • Qualitative methods applied to explore the results from the quantitative analysis Qualitative interview study will seek to identify how the AG campaign was engaged with and the mechanisms of impact from the perspective of those who became AG Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope
  • 17. Thank you Acknowledgements •Public Health England, AMRs and HCAI Programme Team, London: Dr Diane Ashiru-Oredope, Alex Bhattacharya •Public Health England, Field Epidemiology Services, Bristol: Dr Maya Gobin, Dr Isabel Oliver •Health Protection Research Unit in Evaluation of Interventions, School of Social and Community Medicine, University of Bristol: Dr Suzanne M. Ingle The study was supported by the NIHR Health Protection Research Unit in Evaluation of Interventions. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. Combating AMR (CPC Conference) Dr Diane Ashiru-Oredope

Editor's Notes

  1. Invited everyone in the UK – both mop and hcp Video used as an important educational tool
  2. The campaign comprised an online pledge system where individuals were invited to select a pledge from a list tailored for either a health care professionals or members of the public
  3. Invitation to participate in focus groups/in depth interviews
  4. Stata 13.1 Logistic and Ordinal Logistic regression models, adjusted for age, sex and pledge group used to estimate associations between outcomes and AG characteristics Multiple imputation model for the missing values
  5. Imputation results supported the main analysis
  6. Imputation results supported the main analysis
  7. Point 2: Most information comes via the healthcare settings.